Exact Mass: 396.2876

Exact Mass Matches: 396.2876

Found 50 metabolites which its exact mass value is equals to given mass value 396.2876, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

MG(20:3(6,8,11)-OH(5)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C23H40O5 (396.2876)


MG(20:3(6,8,11)-OH(5)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/20:3(6,8,11)-OH(5)/0:0)

1,3-Dihydroxypropan-2-yl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C23H40O5 (396.2876)


MG(0:0/20:3(6,8,11)-OH(5)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

12,20-Dihydroxy-19-acetoxy-14-methylenegeranylnerol

12,20-Dihydroxy-19-acetoxy-14-methylenegeranylnerol

C23H40O5 (396.2876)


   

(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

C23H40O5 (396.2876)


   

denticulatin A

denticulatin A

C23H40O5 (396.2876)


   

palmadorin P

palmadorin P

C23H40O5 (396.2876)


   

MCULE-1023551956

MCULE-1023551956

C23H40O5 (396.2876)


   

Denticulatin B

Denticulatin B

C23H40O5 (396.2876)


   

(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

NCGC00347722-02!(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

C23H40O5 (396.2876)


   

(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid [IIN-based on: CCMSLIB00000847318]

NCGC00347722-02!(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid [IIN-based on: CCMSLIB00000847318]

C23H40O5 (396.2876)


   

(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid [IIN-based: Match]

NCGC00347722-02!(2Z)-2-[(E)-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid [IIN-based: Match]

C23H40O5 (396.2876)


   

PGF2&alpha

9α,11α,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid, isopropyl ester

C23H40O5 (396.2876)


   

24-Nor-5β-cholane-3α,7α,12α,22,23-pentol

24-Nor-5β-cholane-3α,7α,12α,22,23-pentol

C23H40O5 (396.2876)


   

isopropyl ester

9α,11α-dihydroxy-15-oxo-prost-5Z-en-1-oic acid, isopropyl ester

C23H40O5 (396.2876)


   

24-Nor-5beta-cholane-3alpha,7alpha,12alpha,22,23-pentol

24-Nor-5beta-cholane-3alpha,7alpha,12alpha,22,23-pentol

C23H40O5 (396.2876)


   

10-F2-dihomo-IsoP

1a,1b-dihomo-8,12,14-trihydroxy-5Z,9E-prostadienoic acid-cyclo[11,15]

C23H40O5 (396.2876)


   

FA 23:3;O3

1a,1b-dihomo-8,12,14-trihydroxy-5Z,9E-prostadienoic acid-cyclo[11,15]

C23H40O5 (396.2876)


   

ST 23:0;O5

24-Nor-5beta-cholane-3alpha,7alpha,12alpha,22,23-pentol

C23H40O5 (396.2876)


   

benzyl[2-(dodecylamino)-2-oxoethyl]dimethylammonium chloride

benzyl[2-(dodecylamino)-2-oxoethyl]dimethylammonium chloride

C23H41ClN2O (396.2907)


   

2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethanol

2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethanol

C23H40O5 (396.2876)


   

NONOXYNOL-4

NONOXYNOL-4

C23H40O5 (396.2876)


   

4-(5-octyl-2-pyrimidinyl)phenyl heptanoate

4-(5-octyl-2-pyrimidinyl)phenyl heptanoate

C25H36N2O2 (396.2777)


   

Pimilprost

Pimilprost

C23H40O5 (396.2876)


C78568 - Prostaglandin Analogue

   

Radiclonic acid

Radiclonic acid

C23H40O5 (396.2876)


   

[(2S)-2,3-dihydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

[(2S)-2,3-dihydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C23H40O5 (396.2876)


   

1,3-dihydroxypropan-2-yl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

1,3-dihydroxypropan-2-yl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C23H40O5 (396.2876)


   

13,14-dihydro-15-keto prostaglandin f2alpha isopropyl ester

13,14-dihydro-15-keto prostaglandin f2alpha isopropyl ester

C23H40O5 (396.2876)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

C25H36N2O2 (396.2777)


   

1-[(2S,3R,4S)-2-[(cyclobutylmethylamino)methyl]-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-azetidinyl]-1-propanone

1-[(2S,3R,4S)-2-[(cyclobutylmethylamino)methyl]-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-azetidinyl]-1-propanone

C25H36N2O2 (396.2777)


   

cyclobutyl-[(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-(propylaminomethyl)-1-azetidinyl]methanone

cyclobutyl-[(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-(propylaminomethyl)-1-azetidinyl]methanone

C25H36N2O2 (396.2777)


   

1-[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-1-azetidinyl]-2-cyclopropylethanone

1-[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-1-azetidinyl]-2-cyclopropylethanone

C25H36N2O2 (396.2777)


   

N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

C25H36N2O2 (396.2777)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C25H36N2O2 (396.2777)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C23H40O5 (396.2876)


   

(E,2R,4R)-2-[(2S,3S,4S,5R,6R)-2,4-dihydroxy-3,5-dimethyl-6-[(2R)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

(E,2R,4R)-2-[(2S,3S,4S,5R,6R)-2,4-dihydroxy-3,5-dimethyl-6-[(2R)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C23H40O5 (396.2876)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C23H40O5 (396.2876)


   

PGF2alpha isopropyl ester

PGF2alpha isopropyl ester

C23H40O5 (396.2876)


   

DG(20:2)

DG(8:0_12:2)

C23H40O5 (396.2876)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

(2s,5e,7r)-7-hydroxy-2-[(4e)-6-hydroxy-4-(hydroxymethyl)hex-4-en-1-yl]-6,10-dimethyl-9-methylideneundec-5-en-1-yl acetate

(2s,5e,7r)-7-hydroxy-2-[(4e)-6-hydroxy-4-(hydroxymethyl)hex-4-en-1-yl]-6,10-dimethyl-9-methylideneundec-5-en-1-yl acetate

C23H40O5 (396.2876)


   

(2s,4r,6e)-2-[(2s,3s,4s,5r,6r)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

(2s,4r,6e)-2-[(2s,3s,4s,5r,6r)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)


   

2-[(4as,5's,6ar,7r,8r,10as,10br)-5'-(hydroxymethyl)-3,3,6a,8,10b-pentamethyl-octahydrospiro[naphtho[2,1-d][1,3]dioxine-7,2'-oxolan]-5'-yl]ethanol

2-[(4as,5's,6ar,7r,8r,10as,10br)-5'-(hydroxymethyl)-3,3,6a,8,10b-pentamethyl-octahydrospiro[naphtho[2,1-d][1,3]dioxine-7,2'-oxolan]-5'-yl]ethanol

C23H40O5 (396.2876)


   

methyl (2e,7z)-8-hydroxy-2-(1-hydroxy-2-oxopropyl)-6,9-dimethylheptadeca-2,7-dienoate

methyl (2e,7z)-8-hydroxy-2-(1-hydroxy-2-oxopropyl)-6,9-dimethylheptadeca-2,7-dienoate

C23H40O5 (396.2876)


   

(2r,4r,6e)-2-[(2s,3s,4s,5r)-2,4-dihydroxy-3,5-dimethyl-6-(3-oxopentan-2-yl)oxan-2-yl]-4,6-dimethylnon-6-en-3-one

(2r,4r,6e)-2-[(2s,3s,4s,5r)-2,4-dihydroxy-3,5-dimethyl-6-(3-oxopentan-2-yl)oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)


   

(2s,4r,6e)-2-[(2s,3s,4s,5r)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

(2s,4r,6e)-2-[(2s,3s,4s,5r)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)


   

(2r,4r,6e)-2-[(2s,3s,4s,5r,6r)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

(2r,4r,6e)-2-[(2s,3s,4s,5r,6r)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)


   

2-[2,4-dihydroxy-3,5-dimethyl-6-(3-oxopentan-2-yl)oxan-2-yl]-4,6-dimethylnon-6-en-3-one

2-[2,4-dihydroxy-3,5-dimethyl-6-(3-oxopentan-2-yl)oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)


   

2-[5'-(hydroxymethyl)-3,3,6a,8,10b-pentamethyl-octahydrospiro[naphtho[2,1-d][1,3]dioxine-7,2'-oxolan]-5'-yl]ethanol

2-[5'-(hydroxymethyl)-3,3,6a,8,10b-pentamethyl-octahydrospiro[naphtho[2,1-d][1,3]dioxine-7,2'-oxolan]-5'-yl]ethanol

C23H40O5 (396.2876)


   

(2s,4r,6e)-2-[(2s,3s,4s,5r,6s)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

(2s,4r,6e)-2-[(2s,3s,4s,5r,6s)-2,4-dihydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]-4,6-dimethylnon-6-en-3-one

C23H40O5 (396.2876)